| JVMTX | MVCJX | JVMTX / MVCJX | |
| Total Expense Ratio | 0.99 | 0.74 | 134% |
| Annual Report Gross Expense Ratio | 1.10 | 0.75 | 147% |
| Fund Existence | 13 years | 21 years | - |
| Gain YTD | 5.177 | 4.822 | 107% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 24.7B | 17.1B | 144% |
| Annual Yield % from dividends | 0.60 | 1.42 | 42% |
| Returns for 1 year | 4.79 | 2.22 | 216% |
| Returns for 3 years | 11.22 | 12.09 | 93% |
| Returns for 5 years | 22.28 | 27.39 | 81% |
| Returns for 10 years | 76.80 | 108.05 | 71% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BGLD | 18.00 | 0.25 | +1.41% |
| FT Vest Gold Strategy Qt Buffer ETF | |||
| PBE | 82.76 | 0.02 | +0.02% |
| Invesco Biotechnology & Genome ETF | |||
| KLMT | 31.77 | N/A | N/A |
| Invesco MSCI Global Climate 500 ETF | |||
| STXI | 32.76 | -0.05 | -0.17% |
| Strive International Developed Mkts ETF | |||
| ARKG | 30.32 | -0.30 | -0.98% |
| ARK Genomic Revolution ETF | |||